Healthcare Industry News: Elekta
News Release - April 17, 2009
Elekta Sponsors All Are Our Heroes to Raise Cancer AwarenessElekta is proud to now serve as a presenting sponsor for the All Are Our Heroes song project, an effort that uniquely celebrates and supports the efforts to overcome cancer.
ATLANTA, April 17 -- (Healthcare Sales & Marketing Network) -- In our field, where we focus so intently on the science of cancer care, it's easy to lose sight of the human stories and triumphs that are a part of the journey.
Motivated by the Relay for Life events of the American Cancer Society, an inspiring song was written to send a message of faith, hope and love. In just weeks, the song "Heroes" has become an anthem for all those touched by cancer and is at the core of efforts to sustain awareness about the fight against cancer.
David Greer, a Georgia media and marketing entrepreneur, wrote All Are Our Heroes as he reflected on the faces of the people in the Survivor's Walk at his local Relay for Life. His Heroes project is a magical collaboration of creative and musical talent, fueled with the support of corporate citizens and cancer advocates and shared worldwide through social networking and new media.
David enlisted the talents of Rachel Farley, just 14, an up-and-coming country music artist as a co-writer and singer. Grammy-nominated singer-songwriter Shawn Mullins produced the song and added his band to the mix. Joining Mullins and Rachel were some inspirational back-up singers -- six young childhood cancer survivors who add their voices to the song's ending chorus. "The mission is to bring people around the world together to inspire participation and support for cancer advocacy, prevention and research," says Greer. "I'm a dreamer and if you're going to dream, dream big."
"Elekta is proud to embrace and support the Heroes project," stated Joseph K. Jachinowski, President and CEO of Elekta North America. "We'll be adding the Heroes seal and link to our clinical correspondence and spreading the message to our worldwide network of employees. We'll also be identifying our own Elekta Heroes -- courageous individuals and families who are helping to overcome cancer with the aid of the equipment, technology and treatment that Elekta pioneers and delivers."
"Another key element of the project for Elekta is to share the Heroes message with all of our stakeholders -- our hospital and clinical partners -- and we hope that as we bring the message your way, you'll join the effort as well. We are utilizing the power and reach of social networking as a vital part of the Heroes effort -- the All Are Our Heroes Facebook Group is now more than 6,500 strong and growing hourly, with members from 48 states and more than 21 countries," stated Jachinowski.
We encourage you to visit AllAreOurHeroes.com to donate to ACS and order the song, join the Facebook Group and learn more about the project.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.Elekta.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.